CANCER TYPE: MATCH
RESEARCH BASE: ECOG-ACRIN
NCT NUMBER: NCT02465060
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
UPDATED ON 04/11/2019 (20:57:00)
Solid tumor, lymphoma or multiple myeloma that has progressed following at least 1 line of standard systemic therapy OR patients for whose disease no standard treatment exists that has been shown to prolong overall survival. Molecular analysis from a designated outside laboratory that identifies a “rare variant" that is an actionable Mutation of Interest (aMOI) for specific select subprotocols.